SOA Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.7K Sell
870
-15
-2% -$1.26K 0.01% 315
2026
Q1
$70.9K Hold
885
0.01% 317
2025
Q4
$75.4K Hold
885
0.01% 309
2025
Q3
$68.8K Hold
885
0.01% 334
2025
Q2
$69.2K Buy
885
+407
+85% +$30.4K 0.01% 315
2025
Q1
$34.6K Hold
478
0.01% 391
2024
Q4
$35.4K Sell
478
-130
-21% -$9.1K 0.01% 376
2024
Q3
$40.1K Sell
608
-35
-5% -$2.54K 0.01% 353
2024
Q2
$59.4K Sell
643
-95
-13% -$8.41K 0.01% 289
2024
Q1
$70.5K Sell
738
-13
-2% -$1.09K 0.01% 271
2023
Q4
$57.3K Sell
751
-60
-7% -$4.17K 0.01% 282
2023
Q3
$56.2K Hold
811
0.01% 273
2023
Q2
$76.5K Sell
811
-83
-9% -$7.21K 0.02% 254
2023
Q1
$74K Sell
894
-7
-0.8% -$550 0.02% 248
2022
Q4
$67.2K Sell
901
-3
-0.3% -$231 0.02% 252
2022
Q3
$74K Hold
904
0.02% 228
2022
Q2
$85K Sell
904
-11
-1% -$1.14K 0.03% 216
2022
Q1
$107K Hold
915
0.03% 223
2021
Q4
$119K Hold
915
0.03% 197
2021
Q3
$103K Sell
915
-4
-0.4% -$457 0.03% 213
2021
Q2
$95K Sell
919
-16
-2% -$1.51K 0.02% 222
2021
Q1
$78K Sell
935
-106
-10% -$8.96K 0.02% 223
2020
Q4
$89K Buy
+1,041
New +$86.3K 0.02% 204

Other funds holding EW

SOA Wealth Advisors's EW Position: Q2 2026 in Review

SOA Wealth Advisors reduced its Edwards Lifesciences (EW) stake by 1.7% in Q2 2026, selling an estimated $1.26K and leaving 870 shares worth $78.7K. The position accounts for 0.01% of the portfolio, ranked #315.

SOA Wealth Advisors first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $119K in Q4 2021. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • SOA Wealth Advisors held 870 shares of Edwards Lifesciences worth $78.7K as of Q2 2026.
  • SOA Wealth Advisors sold 15 Edwards Lifesciences shares in Q2 2026, an estimated $1.26K.
  • Edwards Lifesciences made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #315 holding.
  • SOA Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's Edwards Lifesciences position peaked at $119K in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.